Anika Therapeutics

ANIK52

$25.02arrow_drop_down1.88%-$0.48

ANIK52

$25.02

arrow_drop_down1.88%-$0.48

Performance History

Key Stats
Open	$25.48
Prev. Close	$25.50
EPS	-5.06
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	24.87	25.54
52 Week Range	17.88	29.12

Ratios







EPS	-5.06

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Anika Therapeutics (ANIK)

Anika Therapeutics Inc (ANIK) is a leading provider of therapeutic solutions for tissue protection, healing, and repair. The company's products are used in a wide range of medical applications, including orthopedics, ophthalmology, and dermatology. With a strong focus on innovation and research, Anika Therapeutics has established itself as a leader in the field of regenerative medicine.

ANIK's stock price history shows a steady upward trend over the years, reflecting the company's consistent growth and strong performance. The stock has experienced periodic fluctuations, but overall, it has shown positive growth. Investors have been drawn to ANIK for its potential for long-term value and its strong position in the market.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Dr. Cheryl Renee Blanchard Ph.D.
Headquarters: Bedford
Employees: 345
Exchange: NASDAQ

Keep an eye on Anika Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Anika Therapeutics 's (ANIK) price per share?

The current price per share for Anika Therapeutics (ANIK) is $25.02. The stock has seen a price change of -$0.48 recently, indicating a -1.88% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Anika Therapeutics (ANIK)?

For Anika Therapeutics (ANIK), the 52-week high is $29.12, which is 16.39% from the current price. The 52-week low is $17.88, the current price is 39.93% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Anika Therapeutics (ANIK) a growth stock?

Anika Therapeutics (ANIK) has shown an average price growth of 0.41% over the past three years. It has received a score of 38 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Anika Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Anika Therapeutics (ANIK) stock price performance year to date (YTD)?

As of the latest data, Anika Therapeutics (ANIK) has a year-to-date price change of 10.41%. Over the past month, the stock has experienced a price change of -2.23%. Over the last three months, the change has been -3.47%. Over the past six months, the figure is -0.28%. Looking at a longer horizon, the five-year price change stands at -52.72%.

help

Is Anika Therapeutics (ANIK) a profitable company?

Anika Therapeutics (ANIK) has a net income of -$82.67M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 61.85% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0.38% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $166.66M, with a revenue growth rate of 6.67%, providing insight into the company's sales performance and growth. The gross profit is $103.09M. Operating income is noted at -$25.45M. Furthermore, the EBITDA is $50.96M.

help

What is the market capitalization of Anika Therapeutics (ANIK)?

Anika Therapeutics (ANIK) has a market capitalization of $377.32M. The average daily trading volume is 72.33K, indicating the stock's liquidity and investor engagement.